FOXO3 and colorectal cancer: In summary, this recent report suggests that the FOXO3a level is low in both colorectal cancer and radioresistant colorectal cancer cells and that increasing the level of FOXO3a leads to a marked therapeutic effect on colorectal cancer patients.